Danaher Beats Q4 Estimates and Issues Upbeat 2026 Profit Guidance

Danaher Corporation reported strong financial results for the fourth quarter of 2025, with an adjusted EPS of $2.23, surpassing analyst expectations. The company's revenue climbed by 4.5% to reach $6.84 billion, supported by technological advancements and strategic investments across its subsidiaries. Looking ahead, Danaher provided an optimistic outlook for 2026, projecting an adjusted EPS range of $8.35 to $8.50. Institutional confidence in the firm was further highlighted by ING Groep NV, which increased its stake in the company by a significant 143.7%. These robust results have effectively offset investor concerns regarding a recent transition within the company's board of directors. The combination of strong earnings and positive forward guidance is expected to support the stock's performance and the broader healthcare sector.